IDO1 and neoplasm: Downregulation of the immune checkpoint molecules IDO1 and VISTA was specifically observed in the ROIs with CD45+ immune cells, while not in the S100+ tumor fields, which is in line with the notion that VISTA is expressed by TIL subsets, and interaction between tumor cells and immune cells is necessary for its expression.